Registered number: 02339750 Charity number: 801382 Kent TAerq¥centre KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) UNAUDITED TRUSTEES. REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) CONTENTS Page Reference and administrative details of the company* its Trustees and advisers Trustees. report Independent examinerfs report Statement of financlal actlvltles Balance sheet 10 Statement of cash flows 11 Notes to the financial statements 12-29
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmited by guarantee) REFERENCE AND ADMINISTRATIVE DETAILS OF THE COMPANY. ITS TRUSTEES AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2024 Trustees Mr J Limmer. Chair Mrs J Tompkins Mr D J Bailey (resigned 31 March 2024) Mrs l Neitsch MrA Cleur Mr P Connolly Mr I Padda {resned 30 April 2024) Ms L Ellis (resigned 30 April 2024) Ms P Kersten {appointed 30 April 2024, resigned 16 May 2025) Mr R Mason (appointed 30 April 2024) Mrs A Foot (appointed 30 September 2024) Mr J Tonkin (appointed 30 September 2024) Company registered number 02339750 Charity registered number 801382 Registered office Bradbury House Merton Lane (North) Canterbury Kent CT4 7DZ Company secretary Mr J Limmer Chief executive officer Ms H Coleman Accountants mag Gammon Chartered Accountants Henwood House Henwood Ashford Kent TN24 8DH Page 1
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD IA company limited by guarantee) TRUSTEES. REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 The Trustees present their annual report together with the financial statements of the company for the 1 January 2024 to 31 December 2024. The Annual report serves the purposes of both a Trustees, report and a directors, report under company law. The Ttustees confirm that the Annual report and financial statements of the charitable company comply wtih the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) (effective 1 January 2019). Since the company qualifies as small under section 382 of the Companies Act 2006, the Stralegic report required of medium and large companies under the Companies Act 200S {strategic Report and Directors, Report) Regulations 2013 has been omitted. Objectives and activittes a. Pollcles and obJe¢tlves The charty is govemed by its Memorandum and Articles of Association and aims to promote the relief of persons in the County of Kent who live wtth Muftiple Sclerosis (MS) and other neurologirAI conditions by any lawful means and in particular and without prejudice to the generality of the foregoing: to provide advice. guidance and moral and practical support for persons living with MS to provide therapy (including oxygen therapy) for persons living with MS or other similar symptoms or condbtions In setting objectbves and planning for activities. the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit. including the guidance 'Public benefit.. wnning a charity (PB2)'. b. Actlvitles for achievlng objectlves To ensufe the charitable company's aims are met, the charitable company has a general policy to bring together persons living with MS and persons interested or more widety affected by MS. The charitable company administers and equips a centre for the provision of therapies. "Active" members are required to pay for membership to the centre. thereafter 11 members are asked for a donation contributing to the operating costslcost of therapy and associate members are required to pay a fixed charge albeit one well below the market rate. The centre also raises funds through events and donations. The major source of funds comes from the enomous support that the charity receives from Trusts and Foundalions without whom the centre would not exist. There have been no material changes in these policies Sin the last report. Page 2
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limtted by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Achievements and perfomiance . Review of activities The charitable company has continued its main objective of providing a range of therapies, support and advice to those with MS. their families and carers. 2024 was the tenth year of operation in the New Centre which continues to provide a state of the art facility to its users and consequently the principal therapies of Physiotherapy & Hydrotherapy, Reflexology. Acupuncture and High Dose Oxygen Therapy have all remained in strong demand. The Centre also continues to treat a range of non-ms conditions with High Dose Oxygen Therapy including some life long conditions such as fibromyalgia. cancer, post-operative wounds and sports injuries, the income from which assists in the subsidising of its services to members with MS. Continual investment in Centre staff has further strengthened the offering available to Centre users. We additionally have recruited four new Trustees to fill skill vacancies. As at the end of 2024 the Charity served 412 MS members and 313 Associate members (a total of 725 members). The Trustees wish to record their grateful thanks to our volunteers and others who willingly donate their time and ServIS to our cause. Their wonderful support ensures that the New Centre continues to provide care and support to members and will continue to do so for the foreseeable future. The Trustees would like the extend a specffic thank you to the Frank Brake Charitable Trust, the William Brake Charitable Trust, the James Tudor Foundation. the February Foundation, the Childwick Trust, Garfield Weston Foundation, the Lawson Trust, the Thomas J Horne Memorial Trust, Kent Community Foundation, Meads Trust, The Loveday Charitable Trust and the Edward Gostling Foundation. b. Publlc awareness The Trustees and the ExecutNe Team continue to promote awpreness of the Centre within the local community. c. Public benefit The Trustees have complied with their duty to have regard to the guidance on public benefrt published by the Charty Commission in exercising their powers or dLrties. The activities of the charity are directed to. providing signifrAnt support for those with MS and other similar conditions both through treatment and therapy, infomial advi and peer support. Any contribution made towards the running costs of the charty is at the discretion of the member with MS and all MS Members have the opportunty to benefft from the activities of the charity wthout charge. The balance of the running cost is subsidised through its fundraising and income generation actiwties. Page 3
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limtted by guarantee} TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Achlevements and perfomiance (continued) d. Achievements and performance oveNiew Kent MS Therapy Centre continues to extend the scope of Iherapies on offer. In 2024, the charity delivered a total of 12,257 sessions of therapy. A summary is shown below. Therapy Data Total Total Distinct Distinct MS Attendances Attendees Attendees Distinct Associate Attendees Acupuncture Ai Chi APS Aqua Yoga Balance Warrior Boxfit Counselling Fit Pump Gym Session HIIT Hydro Induction Hydrotherapy Leisure Swim Massage l Reflexology Melody Singers Oxygen Therapy Physio Assessment Physio Treatment Pilates Podiatry Stretch N Flex Yoga Total 2024 Total 2023 167 10 170 604 13 106 221 12 1,378 33 17 1.272 171 1,934 156 4,589 142 372 239 190 35 426 12,257 13,005 20 12 53 31 19 19 12 23 67 26 10 17 119 33 182 12 52 15 51 65 16 111 251 140 81 31 58 12 52 561. 58 109 86 56 20 39 131 49 23 10 12 39 259. 10 292. 33 This is the total distinct members over all therapies. A member may have accessed multiple therapies but that person will only be counted oncen int eh total distinct count. Therefore the sum of the distinct attendees will not equal the distinct totsl. As we attract more Members with MS and extend our therapy offering the level of subsidy required to support our therapies increases. Fundraising and sustainable income generation becomes ever more important. e. Fundraising and income generation Endowment Funds 2024 175,000 Restricted Unrestricted Total Funds Total Funds Funds Funds 2024 2024 76,773 449,517 31,576 118,785 1,980 3,004 £604.862 2024 701,290 31,576 118,785 3,176 3,004 £857.831 2023 571,132 144,312 114,353 1,487 179 £831,463 Donations and legacies Charitable activities Other trading activities Investments Other income Total income 1.196 £176.196 £76,773 Page 4
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) TRUSTEES. REPORT {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Financial revlew . Going concem After making appropriate enquiries, the Trustees have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements. Further detsils regarding the adoption of the going concem basis can be found in the accounting policies. b. Reserves policy The charitable company has maintained a tight control on expendtture throughout the year. It seeks to maintain a reserve a¢¢ount which is equivalent to 3 months running Costs. whilst recognising that after a Challenging year, it will take time to build reserves to this level. General review Incoming resources for the year amounted to £857,831 {2023 - £831,463) with expenditure totalling £764,029 (2023 - £756,958) resulting in a surplus of £93.802 (2023 - surplus of £74,505). 11 is the Trustees intention to apply all funds received in any one year whilst maintaining an appropriate level of unrestricted reseNes in accordance with the policy. The charity is also grateful to its staff, therapists and volunteers who have assisted with income-generating activities. Restricted funds for speclfic projects have been received during the year from the following sources.. Restrlcted funds recelved In 2024 R G Hills Charitable Trust MS Awar6ness Week Individual Donations The Big Give 2023 Champion Funder H R Pratt Boomian Family Foundation Souter Charitable Trust William Brake Foundation Sir Jules Thom Charitable Twst Garfield Weston Foundation F B Coales No.4 (Family) Trust The Big Give 2024 Individual Donations The February Foundation The Lawson Trust Auction Income from the Christmas Ball Charlotte Marshall Charitable Trust Social Enterprise Kent Kent Community Foundation Alf and Della Fasham Pocock's Solicitors Walker Construction Trust Hilary Brian Greg Mayne Amount Pur £2.000 Physi(F and hydroth8rapy £1.734 Physitr and hydrotherapy £1,875 Physitr and hydrotherapy £1.000 Physitr and hydrotherapy £2,000 Physitr and hydrotherapy £15,000 Physio- and hydrotherapy £3,000 Physio- and hydrotherapy £15,000 Physio- and hydrotherapy £3.000 Physio- and hydrotherapy £10,000 Physio- and hydrotherapy £5,000 Physio- and hydrotherapy £5,000 Physio- and hydrotherapy £1,300 PhysirTr and hydrotherapy £452 Complementary therapies £4,905 Counselling (Mental Health Support Programme) £9,000 Other- Capacity Building £300 Other- Water Heater £335 Other- Water Heater £350 Other- Washing Machine £128 Other- 2 Sumup Machines £300 Other- Window Cleaning Page 5
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Structure. governance and management a. Constitution The company is registered as a charttable company limited by guarantee and was set up by a Memorandum of Association on 5 March 1993. The company 15 a registered charity. number 801382. The princip81 object of the company is the provision of services and support to aid and improve the condition of those living Wth Multiple Sclerosis. b. Methods of appointment or electlon of Trustees Trustees are appointed or reappointed at the Company Annual General Meeting and, under the Articles of Association, hold office for a term of three years and are eligible for reelection for a maximum of three terms with the option to extend this in special circumstances. c. Organlsatlonal structure and decision-making policles The board of trustees is responsible for govemance of the charity and generally meets every month. The board sets the strategic direction and policy for the charity. agrees an annual budget, and monitors performance against it. The day-today management of the Centre is the responsibility of the Executive team. d. Risk management The Trustees have assessed the major risks to which the company is exposed, those related to the operations and finances of the company and are satisfied that systems and procedures are in place to mitigate exposure to the major risks. The support we have had from our donors and sponsors has been unparalleled and very much appreciated; the centre remains in reasonable financial health considering the challenges imposed on fund raising. We remain confident as Trustees that the centre will continue to improve and grow to better support the lives of people living with MS in Kent. Future developments Kent MS Therapy Centre continues to work to make more people wilh MS in Kent aware of the Centre and understand how it can help. Activities towards this aim include collaboration with existing MS support groups such as the MS Society. MS Trust, profile raising amongst NHS specialised groups and clinicians and more effective use of social media, along with continued relationships with mainstream media. Our strategy to 2025 is buiEt on three pillars: Improve our financial sustainabilty by maximising the income from the Centre's building, alongside a new fundraising strategy focusing on multi-year donations. Deliver support for more people wilh MS (and other conditions) acros5 Kent by delivering therapies from other locations, in addition to the Centre in Canterbury. Become rogniSed as a Centre of Excellence: providing leadership in the provision of care and being recognised as an organisation that continues to leam by seeking out knowledge and expertise in the wider community. The executive team have made progress on all 3 pillars of our strategy during 2024. We are delighted with the collaboration with ChristchuKh Universty. Page 6
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD IA company Ilmlted by guardntee) TRUSTEES, REPORT {CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2024 Our Mlsslon "Improving the lives of those Ipiing with MS in Kenv, The Cenlre aims to radically improve the lives of those wÉth Muliiple Sclerosis, their famllles and those who care for them. We alm to: Provide a range of complementary therapie5 and speclalist clinics. Give advice, support and infomiation to those INing with MS, their carers and families, in an environmenl whlch encourages mutual support and friendship, Be a Centre of Excellence which enables self-management of the condilion, Welcome people throughout KenL Statement of Trustees, responslbllltles The Trustees (who are also the directors of the company for the purposes of company law) are responsible for preparing the Trustees, report and the financial statemenls in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financlal . Undar company law, the Trustees must not approve the financial Statements unless they are salisfied that they glve a true and fair view of the state of affairs of the company and of its incomlng resources and application of resources, including its income and expenditure, for that period. In preparlng these financial statements, the Trustees are required to.. select 5Uitable accounllng policies and then appEy them consistently. observe the methtxIs and principles of the Charities SORP (FRS 102): make judgements and accounting estimates that are reasonable and prudent; state whether applicable UK Accounting Stsndards {FRS 102) have been followed, subject to any material deparlures disclosed and explained in the financial statements., prepare the financial statements on the going ¢oncem basis unless it is Inapproprlate to presume that the company will continue in business. The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the companls transactions and disc105e with reasonable accuracy at any time the financial position of the company and enable Ihem to ensure that the financial statements comply with the Companle5 Act 2006. They arè also responsible for safeguarding th8 assets of the company and hence for taking reasonable steps for the prevention and detectDn of fraud and other Irregularities. Approved by order of the members of the board of Trustees on 18 September 2025 and signed on their behalf by. Mr J Llmmer (Chalr of Trustees) Page 7
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmlted by guarantee) INDEPENDENT EXAMINER'S REPORT FOR THE YEAR ENDED 31 DECEMBER 2024 Independent examiner's report to the Trustees of Kent Multiple Sclerosis Therapy Centre Ltd ('the company.) I report to the charity Trustees on my examination of the accounts of the company for the year ended 31 December 2024. Responsibllities and basis of report As the Trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act'}. Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the Company's accounts carried out under section 145 of the Charities Act 2011 ('the 2011 Act,). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5){b) of the 2011 Act. Independent examiner's statement Since the CoMpanS gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confinn that l am qualified to undertake the examination because l am a member of the Instbtute of Chartered Accountants in England and Wales. which is one of the listed bodies. I have completed my examinakn'on. I confim that no matters have come to my attention in connection with the examination giving me Cause to believe- accounting records were not kept in respect of the company as required by section 386 of the 2006 Act. or the accounts do not accord with those records. or the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a 'true and fairf view which is not a matter considered as part of an independent examination- or the a¢¢ounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities [applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)}. I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached. This report is made solely to the companys Trustees. as a body. in accordance with Part 4 of the Charities (Accounts and Reports) Regulations 2008. My work ha5 been undertaken so that I might state to the company's Trustees those matters l am required to state to them in an Independent examineffs report and for no other purpose. To the fullest extent pemiitted by law, I do not accept or assume responsibility to anyone other than the company an the compan$ Trustees as a body, for my work or for this report. Signed- Dated: 18 September 2025 Roland Parry FCA Magee Gammon Chartered Accountants Page 8
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2024 Endowment funds 2024 Restricted Unrestrfcted funds funds 2024 2024 Total funds 2024 Total funds 2023 Note Income and endowments from: Donations and legacies Charitable activities Other trading activities Investments Other income 175,000 81,678 449.517 31.576 113.880 1.980 3,004 706.195 31.576 113.880 3,176 3,004 571, 132 144,312 114,353 1,487 179 1.196 Total income and endowments 176,196 81.678 599,957 857,831 831,463 Expendlture on: Raising funds Charitable activities 137,147 520.071 137,147 626,882 130,927 626, Q31 106,811 Total expenditure 106,811 657.218 764.029 756, 958 Net Incomel(expenditure) Transfers between funds 176,196 (25.133) (57,261) 93.802 74,505 19 135,000) 35.000 Net movement in funds 141.196 9.867 (57.261) 93.802 74,505 Reconclllatlon of funds: Total funds brought forward Net movement in funds 22.804 9.867 1.544,135 (57,261) 1,566,939 93.802 1,492, 434 74,505 141.196 Total funds carrled forward 141,196 32,671 1.486,874 1,660,741 1,566,939 The Statement of financial adivities includes all gains and losses recognised in the year. The notes on pages 12 to 29 fonn part of these financial statements. Page 9
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A company Ilmlted by guarantee) REGISTERED NUMBER: 02339750 BALANCE SHEET AS AT 31 DECEMBER 2024 2024 2023 Note Flxed assets Tangible assets Current assets 14 1,441,467 1,467,241 Debtors Cash at bank and in hand 15 17,910 272,697 15.311 163, 732 290,507 179.043 Creditors.. amounts falling due wtthin one year 16 128,36n (21, 870) Net current assets 262,150 157,173 Credltors.. amounts falling due after mote than one year 17 (42,876} (57.475) Total net assets 1,660,741 1, 566, 939 Charlty funds Endowment funds Restricted funds Unrestricled funds 19 19 19 141,196 32,671 1,486,874 22, 894 1,544, 135 Total funds 1,660,741 1, 566,939 The company was entitled to exemption from audit under Section 477 of the Companles Act 2006. The members have not required the company to obtain an audit for the year in question in accordance with section 476 of Companies Act 2006. The Trusteès acknowledge their responsibilities for complwng with the requirements of the Act with respect to accounting records and preparation of financial stalements. The financial statements have been prepared in accordance with the provisions applicable to entitles subject to the small companies regime. The financial statements were appioved and authorised for issue by the Trustees on 18 September 2025 and 51gned on their behalf by. Mr J Llmmer (Chair of Trustees) The notes on pages 12 to 29 form part of these financial statements. Page 10
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2024 2024 2023 Cash flows from operating actlvltles Net cash used in operating activities 122,192 106, 153 Cash flows from investing activities Purchase of tangible fixed assets (113,484) Net cash provided byl{used in} investing activities (113.484) Cash flows from financing activities Cash inflows from new bo0w[ng Repayments of borrowing 77,000 (9.279) (13,327) Net cash (used inyprovided by financing activities (13,327} 67,721 Change in cash and cash equivalents in the year Cash and cash equivalents at the beginning of the year 108,865 60,390 163,732 103,342 Cash and cash equivalents at the end of the year 272,597 163, 732 The notes on pages 12 to 29 forni part of these financial statements Page 11
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 General infomlatlon The Kent Muttiple Sclerosis Therapy Centre Limited is a private company, limited by guarantee. incorporated in England and Wales. The company registration number is 02339750. The registered office address is Bradbury House, Merton Lane (North), Canterbury. Kent, CT4 7DZ. Accounting policies 2.1 Basls of preparatlon of financlal statements The financial statements have been prepared in accordance with the Charities SORP (FRS 102) Accounting and Reporting by Chartiies.. Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. Kent Multiple Sclerosis Therapy Centre Ltd meets the definition of a public benefrt entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otheise stated in the relevant accounting polw. 2.2 Income All income is recognised once the company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably. The recognition of income from legacies is dependent on establishing entitlement. the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when Èt is probable that ti WIIS be received and the fair value of the amount receivable. which will generally be the expected cash amount to be distributed to the company, Can be reliably measured. Grants are included in the Statement of financial activities on a receivable basis. The balance of income received for specffi¢ purposes but not expended during the period is shown in the relevant funds on the Balance sheet. Where income is received in advance of entitlement of receipt, its recognition is defeed and included in creditors as deferred income. Where entttlement occurs before income is received, the income is accrued. Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable. other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service. Page 12
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policies (Continued) 2.3 Expenditure Expenditure is recognised On there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each actiwty. Direct Gosts attributable to a single activity are allocated directly to that activty. Shared costs which contribute to more than one activty and support costs which are not attributable to a single activty are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset's use. Expenditure on charitable activities is incurred on directly undertaking the activities which further the company's objedives, as well as any associated support costs. All expenditure is inclusive of irrecoverable VAT. 2.4 Interest recelvable Interest on funds held on depostt is included when ceIVable and the amount Can be measur8d reliably by the company- this is nomally upon notrfication of the interest paid or payable by the institution with whom the funds are deposÈted. 2.5 Tanglble fixed assets and depreciation Tangible fixed assets costing £NIL or more are ¢apitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably. Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost. Depreciation is charged so as to allocate the Cost of tangible fixed assets less their residual value over their estimated useful lives, as below. Depreciation is provided on the following basi5: Buildings Plant and machinery Fixtures and ftttings Computer equipment 20A straight line basis 10'A straight line basis 20 /• reducing balance basis 33 /• Straight line basis 2.6 Debtors Trade and other debtors are recognised at the setllement amount after any trade discount offered. Prepayments are valued at the amount prepatd net of any trade discounts due. 2.7 Cash at bank and In hand Cash at bank and in hand includes cash and short-tetm highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account. Page 13
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A Company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Accounting policies (continued) 2.8 Llabilitles and provlsfons Liabilities a recognised when there is an obligation at the Balance sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliabty. Liabilities are recognised at the amount that the company anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide. Provisions are measured at the best estimate of the amounts requId to settle the obligalion. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of financial activities as a finance cost. 2.9 Financial instruments The company onty has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instrument5 are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method. 2.10 Operating leases Rentals paid under operating leases are charged to the Statement of financial activities on a straight- line basis over the lease term. 2.11 Pensions The company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the company to the fund in respect of the year. 2.12 Fund accountlng General funds are unrestricted funds which are available for use at the discretion of Ihe Trustees in furtherance of the general objectives of the company and which have not been designated for other purposes. Designated funds comprtse unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements. Restricted funds are funds which are to be used in accordance with specrfic restrictions imposed by donors or which have been raised by the company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements. Investment income, gains and k)sses are allocated to the appropriate fund. Page 14
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Income from donatlons and legacies Endowment Restricted Unrestricted funds funds funds 2024 2024 2024 Total funds 2024 Total funds 2023 Donations Legacies Grants Treatment donations 175.000 14.096 105,704 3,549 119,200 221.064 294.800 3.549 186.782 221.064 62,051 66, 842 240, 773 201,466 67.582 175,000 81,678 449.517 706,195 571, 132 Total 2023 97,260 473,872 571. 132 Income from charitable activities Unrestrlcted funds 2024 Total funds 2024 Total funds 2023 Membership subscriptions Rental income 20.835 10,741 20,835 10,741 25,675 118.637 31,576 31,576 144,312 Total 2023 144,312 144.312 Page 15
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Income from other trading activities Income from fundraising events Unrestricted funds 2024 Total funds 2024 Total funds 2023 Fundraising events Sale of goods and literature 67.041 46,839 67,041 46,839 67,999 46.354 113.880 113.880 114,353 Total 2023 114,353 114,353 Investment income Endowment Unrestricted funds funds 2024 2024 Total funds 2024 Total funds 2023 Bank interest receivable Investment income 1.196 1,196 1,980 1.980 1,487 1,196 1,980 3,176 1,487 Total 2023 1,487 1,487 Other Incoming resources Unrestricted funds 2024 Total fund5 2024 Total funds 2023 Income generated from solar panels 3,004 3,004 179 Total 2023 179 179 Page 16
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limfted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 Expenditure on ralslng funds Fundraising expenses Unrestricted funds 2024 Total funds 2024 Total funds 2023 Allocated centrally incurred fundraising and govemance costs 137,147 137,147 130,927 Total 2023 130,927 130,927 Anatysis of expenditure on charltable actlvlties Summary by fund type Restricted Unrestricted funds funds 2024 2024 Total 2024 Total 2023 Charitable activities 106,811 520,071 626,882 626,031 Total 2023 82. 193 543.838 626,031 10. Analysis of expendtture by activilies Activrties undertaken directly 2024 Support costs 2024 Total funds 2024 Total funds 2023 Charitable activities 319,813 307,069 626.882 626,031 Total 2023 330, 204 295.827 626.031 Page 17
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limlted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 10. Analysls of expenditure by activitie5 Icontinued) Analysis of direct costs Total funds 2024 Total funds 2023 Activities 2024 Wages and salaries maintenan of equipment and buildings Oxygen Physiotherapy, reflexology and counselling Training courses Depreciation Govemance costs 117,141 34,584 24.847 99.579 3.896 37.498 2,268 117.141 34.584 24,847 99.579 3.896 37,498 2,268 108,341 19,000 25, 138 133.537 1.587 40.321 2,280 319,813 319,813 330,204 Total 2023 330,204 330,204 Page 18
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 10. Analysls of expendlture by activftles (contlnued) Analysis of support Costs Total funds 2024 Total funds 2023 Activities 2024 Wages and salaries Travelling expenses Cleaning and general costs Printing, postage, stationery and copies Advertising and recruitment Telephone Insurance Rent and rates Light and heat Licences and subscriptions Bank charges Computer and website expenses Sundry expenses Loan charges and interest Professional fees 169,296 2,232 35,079 1.950 857 7,043 9,206 5,125 19.913 22,312 3,837 19,671 962 5,923 3.663 169,296 2,232 35.079 1.950 857 7,043 9.206 5,125 19,913 22,312 3,837 19,671 962 5.923 3.663 184,235 925 24,460 2,195 2.385 7.413 6,877 30,219 10,654 3,272 12,456 1,070 6, 506 2,160 307,069 307,069 295. 827 Total 2023 295,827 295,827 Analysis of fundraising costs 2024 2023 Wages and salaries Fundraising expenditure Cost of goods sold 99.348 35.894 1.905 97,282 30, 502 3.143 137,147 130, 927 Page 19
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 11. Independent examinerfs remuneratlon 2024 2023 Fees payable to the CoMpanS independent examiner for the independent examination of the companls annual accounts 2.268 2,280 12. Staff costs 2024 2023 Wages and salaries Social security costs Contribution to defined contribution pension schemes 353,705 24,543 7,537 357,374 24, 758 7, 726 385,785 389, 858 The average number of persons employed by the company during the year was as follows.. 2024 2023 Employees 16 17 The number of employees whose employee beneffts (excluding employer pension costs) exceeded £60,000 was.. 2024 No. 2023 No. In the band £60,001- £70,01)0 The key management personnel of the company comprise the Trustees and the Chief Executive. The total employee benefrts of the key management personnel of the Charity was £63,750 (2023 - £62,132). 13. Trustees. remuneratlon and expenses During the year. no Twstees reiVed any remuneration or other benefits (2023 - £NIL). During the year ended 31 December 2024, no Twstee expenses have been incurred (2023- £NIL). Page 20
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmlted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 14. Tangible fixed assets Long4emi leasehold property Plant and Fixtures and machinery rittings Computer equipment Total Cost or valuation At 1 January 2024 Additions 1,684,438 146,462 11.724 75,973 52,406 1,959,279 11,724 At 31 December 2024 1,684,438 158.186 75,973 52,406 1,971,003 Depreciation At 1 January 2024 Charge for the year 258,727 23,410 121,937 12.441 60,246 3,142 51,128 (1,495) 492,038 37,498 At 31 December 2024 282,137 134,378 63,388 49,633 529,536 Net book value At 31 December 2024 1.402,301 23,808 12,585 2,773 1 ,441,467 At 31 December 2023 1,425,711 24.525 15,727 1,278 1,467,241 15. Debtors 2024 2023 Due wlthln one year Trade debtors Prepayments and accrued income 4,351 13,559 4, 765 10,546 17,910 15,311 Page 21
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD IA company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 16. Creditors: Amounts falling due withln one year 2024 2023 other loans Trade creditors Other creditors 14.598 10.218 1,206 2,335 13,326 5.574 970 2.000 Accruals and deferred income 28,367 21,870 17. Creditors: Amounts falling due after more than one year 2024 2023 other loans 42,876 57.475 18. Financial instruments 2024 2023 Flnanclal assets Financial assets measured at fair value through income and expenditure 272,597 163, 732 Financial assets measured at fair value through income and expenditure comprise of cash at bank and in hand. Page 22
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 19. Statement of funds statement of funds - current year Balance at 31 December 2024 Balance at 1 January 2024 Transfers inlout Income Expenditure Unrestricted funds Deslgnated funds Designated Funds 1,467,241 125.774) 1.441.467 General funds General Funds 76,894 599,957 {657,218) 25,774 45,407 Total Unrestricted funds 1.544.135 599.957 (657.218} 1,486,874 Endowment funds Expendable endowment funds Bank interest attributable 175.000 {35,000) 140,000 1,196 176,196 {35.000) 141.196 Restrfcted funds Complementary Therapies Counselling Other Physiotherapy and Hydrotherapy 452 4.905 10,413 1452) (6A75) 147.642) 4,000 2,229 2,430 35,000 16.575 65,908 (52,2421 30,241 22,804 81.678 (106.8111 35,000 32,671 Total of funds 1.566.939 857.831 (764,029) 1,660,741 Page 23
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company Ilmkted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 19. Ststement of funds (¢ontlnued) Ph iothera and H drothera The balance of funds donated last year by the Mike Butcher Donation of £10,555 was utilised during the year. The balance of funds donated last year by The Big Give 2023 of £6,020 was Lrtilised durtng the year. R G Hills Charitable Trust donated £2.000. This was utiltsed during the year. MS Awareness Week donations totalted £1,734. Of this. £1.400 was utilised during the year and £334 has been carried forward. The Big Give Christmas Challenge 2023 Champion Funder donated £1.875. This was utilised during the year. H R Pratt Boorman Family Foundation donated £1,000. This was utilised during the year. Souter Charitable Trust donated £2,000. This was utilised during the year. William Brake Foundation donated £15.000. This was utilised during the year. Sir Jules Thom Charitable Trust donated £3,000. This was utilised during the year. Garfield Weston Foundation donated £15,000. Of this. £2.226 was utilised during the year and £12,774 has been carried foard. F B Coales No.4 (Family) Trust donated £3,000. This YS utilised during the year. Big Give Christmas Challenge 2024 individual donations totalled £10,01)O. Of this, £2,870 was utilised during the year and £7,130 has been ¢arrFed forward. The February Foundation donated £5.000. This has been carried foNiard. The Lawson Trust donated £5.IX)O. This has been carried forward. Auction income from the Christmas Ball 2024 totalled £1.300. Of this, £1,297 was utilised during the year and £3 has been carried forward. Com lementa Thera ies Charlotte Marshall Charitable Trust donated £452. This was utilised during the year. Counsellin The balanc6 of funds donated last year by Beerling Foundation of £1,250 was Lrtilised during the year. The balance of funds donated last year by Cantiacorum Foundation of £500 was utilised during the year. The balance of funds donated last year by The Grace Trust of £1,000 was utilised during the year. The balance of funds donated last year by The Sir James Roll Charitable Trust of £1,250 was utilised during the year. Social Enterprise Kent donated £4,905. Of this. £2.475 was utilised during the year and £2,430 has been carried forward. Page 24
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 19. Statement of funds (continued) othèr Of the balance of funds donated last year by an anonymous individual of £2,229 towards Beacon CRM was utilised during the year. Kent Community Foundation donated £9.000. This was utilised during the year. ASf and Della Fasham donated £300. This was utilised during the year. Pocock's Solicitors donated £335. This was utilised during the year. Walker Construction Trust donated £350. This was uiilised during the year. Hilary Brian donated £128. This was utilised during the year. The Edward Gostling Fund donated endowment funds of £175,000. The funds are to be utilised over 5 years and are expendable. £35,000 was transfeed to restricted ndS and was utilised during the year leaving £140,000 to be carried forward. Desi nated fund This fund has been set aside to cover the investment in fixed assets. The transfers between this fund and the general fund is for the movement in the value of the fixed assets up to the year end date. Page 25
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD {A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 19. Ststement of funds (continued) Statsment of funds - prior year Balance 8t 31 December 2023 Balance at 1 January 2023 Transfe in/out Income Expenditure Unrestrlcted funds Designated funds Designated Funds 1,394.078 73,163 1,467,241 General funds General Funds 63. 186 734.203 (674, 765) (45, 730) 76,894 Total Unrestricted funds 1.457,264 734.203 (674, 765) 27,433 1,544, 135 Restricted funds Complementary Therapies Counselling Other Oxygen Therapy Physiotherapy and Hydrotherapy 4,900 1.718 6.379 1.982 15.725 (20.625) (5.718) (7, 150) (6,435) 27,062 4.453 (24,062) 2,229 20, 191 42,020 (42,265) (3,371) 16,575 35.170 97.260 (82, 193) (27,433) 22,804 Total of funds 1,492,434 831,463 (756,958) 1,566,939 Page 26
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limlted by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 20. Summary of funds Summary of funds- currentyear Balance at 31 December 2024 Balance at 1 January 2024 Transfers Inlout Income Expendlture Designated funds General funds Endowment funds Restricted funds 1,467.241 76,894 (25,774) 1,441,467 25,774 45,407 {35.0001 141,196 35.000 32,671 599.957 176.196 81.678 (657,218) 22,804 (106,8111 1,566,939 857,831 (764.029} 1,660,741 Summary of funds - prior year Balance al 31 D9cember 2023 Balance at 1 January 2023 TnSfe in/out Incon7e Expenditure Designated funds General funds Restricted funds 1.394,078 63, 186 35.170 73, 163 (45. 730) (27,433) 1,467,241 76,894 22,804 734,203 97,260 (674, 765) (82, 193) 1,492.434 831.463 (756,958) 1,566,939 21. Analysls of net assets between funds Analysis of net assets between funds - current period Endowment Restricted Unrestricted funds funds funds 2024 2024 2024 Total funds 2024 Tangible fixed assets Current assets Creditors due within one year Creditors due in more than one year 1,441,467 116,640 (28,357) (42,876) 1,441,467 290,507 128,357) (42,876) 141.196 32,671 Total 141,196 32.671 1,486,874 1,660,741 Page 27
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 21. Analysis of net assets between funds {continuedl Analysls of net assets between funds - prfor perlod Restricted Unrestricted fvnds funds 2023 2023 Total funds 2023 Tangible fixed assets Current assets Creditors due within one year Creditors due in more than one year 1.467,241 156,239 (21,870) (57,475) 1,467,241 179,043 (21,870) (57,475) 22,804 Total 22,804 1, 544, 135 1,566, 939 22. Reconciliation of net movement in funds to net cash flow from operating actlvltles 2024 2023 Net income for the period (as per Statement of Financial Activities) 93,802 74,505 Adjustments for: Depreciation charges Increase in debtors Increase in creditors 37,498 {2,599) 5,215 40.321 (11,452) 2, 779 Net cash provlded by operatlng actlvttles 133.916 106, 153 23. Analysis of cash and cash equivalents 2024 2023 Cash in hand 272,597 163, 732 Total cash and cash equivalents 272,597 163, 732 Page 28
KENT MULTIPLE SCLEROSIS THERAPY CENTRE LTD (A company limited by guarantee) NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024 24. Analysis of changes in net debt At1 January 2024 Cash ftows At31 December 2024 Cash at bank and in hand Debt due within 1 year Debt due after 1 year 163.732 (13.326 157,475 108,865 (1.272) 14,599 272,597 (14,598) (42,876) 92.931 122,192 215,123 25. Pension commitments The charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the charity in an independently administered fijnd. The pension cost charge represents contributions payable by the charity to the fund and amounted to £7,537 (2023 £7,726). Contributions totalling £nil (2023 - £nil) yre payable to the fund at the balance sheet date and are included in creditors. 26. Operatlng lease commltments At 31 December 2024 the company had commitments to make future minimum lease payments under non-cancellable operating leases as follows= 2024 2023 Not later than 1 year Later than 1 year and not later than 5 years Later than 5 years 1,000 4,000 114.000 4,000 115,000 119,000 120,000 27. Members. liability Each member of the chatitable company undertakes to contribute to the assets of the company in the event of it being wound up while they are a member, or within one year after they cease to be a member, such amount as may be required. not exceeding £1 for the debts and liabilities contracted before they cease to be a member. 28. Related party transactions The company has not entered into any related party transaction during the year, nor are there any outstanding balances ov4ing between related parties and the company at 31 December 2024. Page 29